Luci A. Power is an independent lecturer and consultant on pharmacy IV and hazardous drug systems. She was with the Department of Pharmaceutical Services at the University of California Medical Center in San Francisco for over 25 years serving in various capacities, including Senior Pharmacist and Manager of the Parenteral Support Services and Manager of the IV Additive Services where she was responsible for the in-patient chemotherapy and other hazardous drug compounding.
Luci is a primary author of both the 1985 and 1990 ASHP Technical Assistance Bulletins on Handling Cytotoxic and Hazardous Drugs; lead author of the 2006 ASHP Guidelines on Handling Hazardous Drugs and first author of the ASHP Safe Handling of Hazardous Drugs Video Training Program. Luci is an original member of the National Institute for Occupational Safety and Health (NIOSH) working group on hazardous drugs and an author of the 2004 NIOSH Alert: Preventing Occupational Exposures to Antineoplastics and Other Hazardous Drugs in Health Care Settings.
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Thomas Connor, PhD, Research Biologist, National Institute for Occupational Safety and Health
Dr. Connor received his bachelors and masters degrees from the University of Rhode Island. He received his doctoral degree in Environmental Toxicology from the University of Texas Medical Branch. He then joined the faculty of the University of Texas, School of Public Health in Houston, where he taught courses in Genetic Toxicology, Toxicology and Environmental Health for 20 years. Following a fellowship at the National Institute for Occupational Safety and Health, he took a position as a Research Biologist in the Division of Applied Research and Technology and is the Project Officer for a study that examined the potential effects of hazardous drugs on healthcare workers and is also conducting an evaluation of personal protective clothing used in the healthcare industry. He was a primary contributor to the NIOSH Alert on Hazardous Drugs and is responsible for updating the list of hazardous drugs in the Alert. He is involved in writing several NIOSH publications related to the Alert. He was co-chair of a committee that developed the International Society of Oncology Pharmacy Practitioners standard for the safe handling of cytotoxic drugs. He is a member of the ASHP, ISOPP, the Environmental Mutagen Society, and the American Society of Testing and Materials. Dr. Connor was awarded the 2008 ASHP Board of Directors’ Award honoring non-pharmacists for their contribution to the practice of pharmacy. Dr. Connor’s research area has focused on occupational exposure to hazardous drugs in healthcare settings and he has lectured extensively on the topic nationally and internationally.
Luci A. Power is an independent lecturer and consultant on pharmacy IV and hazardous drug systems. She was with the Department of Pharmaceutical Services at the University of California Medical Center in San Francisco for over 25 years serving in various capacities, including Senior Pharmacist and Manager of the Parenteral Support Services and Manager of the IV Additive Services where she was responsible for the in-patient chemotherapy and other hazardous drug compounding.
Luci is a primary author of both the 1985 and 1990 ASHP Technical Assistance Bulletins on Handling Cytotoxic and Hazardous Drugs; lead author of the 2006 ASHP Guidelines on Handling Hazardous Drugs and first author of the ASHP Safe Handling of Hazardous Drugs Video Training Program. Luci is an original member of the National Institute for Occupational Safety and Health (NIOSH) working group on hazardous drugs and an author of the 2004 NIOSH Alert: Preventing Occupational Exposures to Antineoplastics and Other Hazardous Drugs in Health Care Settings.
SPEAKER:
Click the plus sign to see more detailed information about each speaker.
Luci A. Power is an independent lecturer and consultant on pharmacy IV and hazardous drug systems. She was with the Department of Pharmaceutical Services at the University of California Medical Center in San Francisco for over 25 years serving in various capacities, including Senior Pharmacist and Manager of the Parenteral Support Services and Manager of the IV Additive Services where she was responsible for the in-patient chemotherapy and other hazardous drug compounding.
Luci is a primary author of both the 1985 and 1990 ASHP Technical Assistance Bulletins on Handling Cytotoxic and Hazardous Drugs; lead author of the 2006 ASHP Guidelines on Handling Hazardous Drugs and first author of the ASHP Safe Handling of Hazardous Drugs Video Training Program. Luci is an original member of the National Institute for Occupational Safety and Health (NIOSH) working group on hazardous drugs and an author of the 2004 NIOSH Alert: Preventing Occupational Exposures to Antineoplastics and Other Hazardous Drugs in Health Care Settings.
LEARNER OUTCOMES:
Compare and contrast Closed System Drug Transfer Devices (CSTD) as defined in the NIOSH Alert, the ASHP Guidelines and the 2008 USP Chapter <797>.
Compare primary engineering controls and ventilation concerns recommended in the NIOSH Alert and ASHP Guidelines to the new requirements in the 2008 USP Chapter <797>.
Differentiate between work practice recommendations in the NIOSH Alert and the ASHP Guidelines and the requirements in the 2008 USP Chapter <797>.
Identify the National Institute for Occupational Safety's (NIOSH) continuing activities in the area of worker exposure to hazardous drugs.
Outline the primary recommendations for a medical surveillance program for health care workers exposed to hazardous drugs as listed in the NIOSH Workplace Solution.